Allogene Therapeutics Inc (ALLO)
Healthcare
Biotechnology
1.80 $
-2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Allogene Therapeutics Inc (ALLO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -149 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -45 | -45 | -137 | -115 | -185 | -221 | -238 | -200 | -149 | |
| 1.0 | 1.5 | 5.0 | 7.6 | 10 | 14 | 14 | 14 | 12 | |
| – | 19 | 46 | 65 | 81 | 84 | 66 | 52 | 38 | |
| 150 | 130 | 53 | 69 | 81 | 94 | – | – | – | |
| 0.0 | 12 | -6.9 | 54 | -32 | 3.7 | -15 | -25 | -11 | |
| 5.3 | 3.2 | 51 | 66 | 21 | 5.2 | 1.5 | 0.7 | 0.4 | |
| -633 | -633 | 164 | -505 | 164 | 106 | 163 | 76 | 96 | |
| – | 654 | 1.8 | 2.8 | 3.6 | 2.5 | 2.5 | 1.5 | 0.9 | |
| 117 | 117 | – | – | – | – | – | – | – | |
| 771 | 771 | 59 | 634 | 12 | 3.0 | 96 | 117 | 30 | |
| 94 | 94 | 86 | 13 | -9.2 | -111 | 21 | -7.9 | -24 | |
| – | -48 | -188 | -181 | -206 | -226 | -239 | -201 | -150 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.